S&P 500   4,970.63 (-0.81%)
DOW   37,864.79 (+0.24%)
QQQ   415.91 (-1.77%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,970.63 (-0.81%)
DOW   37,864.79 (+0.24%)
QQQ   415.91 (-1.77%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,970.63 (-0.81%)
DOW   37,864.79 (+0.24%)
QQQ   415.91 (-1.77%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
S&P 500   4,970.63 (-0.81%)
DOW   37,864.79 (+0.24%)
QQQ   415.91 (-1.77%)
AAPL   164.27 (-1.66%)
MSFT   398.62 (-1.40%)
META   480.39 (-4.27%)
GOOGL   152.67 (-2.14%)
AMZN   174.37 (-2.71%)
TSLA   148.39 (-1.03%)
NVDA   807.91 (-4.58%)
AMD   148.64 (-4.15%)
NIO   3.80 (-5.00%)
BABA   68.47 (-0.60%)
T   16.31 (-0.12%)
F   12.05 (-0.08%)
MU   106.85 (-4.54%)
GE   147.29 (-3.69%)
CGC   7.93 (+1.28%)
DIS   111.61 (-0.73%)
AMC   3.20 (+9.59%)
PFE   25.77 (+1.50%)
PYPL   61.87 (-0.37%)
XOM   119.58 (+0.89%)
Free Trial

Quince Therapeutics (QNCX) SEC Filings & 10K Form

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free QNCX Stock Alerts
$1.05
-0.01 (-0.94%)
(As of 12:33 PM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Recent Quince Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/11/2024
3:39 PM		Quince Therapeutics (Filer)
Form PRE 14A
04/01/2024
4:21 PM		Quince Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/01/2024
3:50 PM		Quince Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
5:09 PM		Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2024
5:14 PM		Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
8:00 AM		Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
Form SC 13G
02/07/2024
9:50 AM		BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
Form SC 13G/A
02/02/2024
5:02 PM		Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:50 PM		Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
4:53 PM		Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:00 PM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
3:48 PM		Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:08 PM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
5:21 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:30 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
12:38 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
4:54 PM		Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
6:42 PM		Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
6:43 PM		Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/24/2023
6:46 PM		Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2023
6:34 PM		Janhofer Guenter (Reporting)
Quince Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
3:05 PM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
4:40 PM		Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/06/2023
4:43 PM		Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
6:18 AM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
5:42 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
5:08 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
5:18 PM		McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
5:21 PM		Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2023
5:23 PM		Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
6:16 AM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
10:07 AM		BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
Form SC 13G
05/26/2023
4:45 PM		Bray June (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:47 PM		Lamond David (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:49 PM		McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:50 PM		Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:53 PM		Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
3:23 PM		Quince Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:QNCX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
1970’s computer coder issues shocking A.I. warning
TradeSmith